nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorzoxazone—CYP2A6—prostate cancer	0.144	0.35	CbGaD
Chlorzoxazone—CYP2E1—prostate cancer	0.103	0.248	CbGaD
Chlorzoxazone—CYP1A1—prostate cancer	0.101	0.245	CbGaD
Chlorzoxazone—CYP3A4—prostate cancer	0.0646	0.156	CbGaD
Chlorzoxazone—CYP1A1—Flutamide—prostate cancer	0.0488	0.125	CbGbCtD
Chlorzoxazone—CYP1A1—Estrone—prostate cancer	0.0353	0.0903	CbGbCtD
Chlorzoxazone—CYP2E1—Estrone—prostate cancer	0.0272	0.0698	CbGbCtD
Chlorzoxazone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0262	0.0672	CbGbCtD
Chlorzoxazone—CYP1A2—Flutamide—prostate cancer	0.0218	0.0558	CbGbCtD
Chlorzoxazone—CYP2D6—Bicalutamide—prostate cancer	0.0217	0.0555	CbGbCtD
Chlorzoxazone—CYP1A1—Estradiol—prostate cancer	0.0203	0.0519	CbGbCtD
Chlorzoxazone—CYP2D6—Abiraterone—prostate cancer	0.018	0.046	CbGbCtD
Chlorzoxazone—CYP2E1—Mitoxantrone—prostate cancer	0.0162	0.0415	CbGbCtD
Chlorzoxazone—CYP1A2—Estrone—prostate cancer	0.0158	0.0403	CbGbCtD
Chlorzoxazone—CYP3A4—Bicalutamide—prostate cancer	0.0138	0.0353	CbGbCtD
Chlorzoxazone—CYP3A4—Estramustine—prostate cancer	0.0128	0.0328	CbGbCtD
Chlorzoxazone—CYP3A4—Abiraterone—prostate cancer	0.0114	0.0292	CbGbCtD
Chlorzoxazone—CYP3A4—Flutamide—prostate cancer	0.0114	0.0292	CbGbCtD
Chlorzoxazone—CYP1A2—Conjugated Estrogens—prostate cancer	0.0103	0.0264	CbGbCtD
Chlorzoxazone—CYP2E1—Etoposide—prostate cancer	0.0102	0.0262	CbGbCtD
Chlorzoxazone—CYP1A2—Estradiol—prostate cancer	0.00905	0.0232	CbGbCtD
Chlorzoxazone—CYP3A4—Cabazitaxel—prostate cancer	0.00845	0.0216	CbGbCtD
Chlorzoxazone—CYP3A4—Estrone—prostate cancer	0.00826	0.0211	CbGbCtD
Chlorzoxazone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00736	0.0188	CbGbCtD
Chlorzoxazone—Urine color abnormal—Flutamide—prostate cancer	0.00666	0.086	CcSEcCtD
Chlorzoxazone—CYP1A2—Etoposide—prostate cancer	0.00591	0.0151	CbGbCtD
Chlorzoxazone—CYP3A4—Conjugated Estrogens—prostate cancer	0.0054	0.0138	CbGbCtD
Chlorzoxazone—CYP3A4—Mitoxantrone—prostate cancer	0.00491	0.0126	CbGbCtD
Chlorzoxazone—CYP3A4—Estradiol—prostate cancer	0.00474	0.0121	CbGbCtD
Chlorzoxazone—Chromaturia—Flutamide—prostate cancer	0.0044	0.0568	CcSEcCtD
Chlorzoxazone—CYP3A4—Prednisone—prostate cancer	0.00408	0.0104	CbGbCtD
Chlorzoxazone—CYP2D6—Doxorubicin—prostate cancer	0.00332	0.0085	CbGbCtD
Chlorzoxazone—CYP3A4—Etoposide—prostate cancer	0.0031	0.00793	CbGbCtD
Chlorzoxazone—CYP3A4—Docetaxel—prostate cancer	0.00283	0.00725	CbGbCtD
Chlorzoxazone—Urine color abnormal—Mitoxantrone—prostate cancer	0.00248	0.0321	CcSEcCtD
Chlorzoxazone—CYP3A4—Doxorubicin—prostate cancer	0.00211	0.00541	CbGbCtD
Chlorzoxazone—CYP1A2—urine—prostate cancer	0.002	0.101	CbGeAlD
Chlorzoxazone—CYP2E1—urine—prostate cancer	0.0018	0.0906	CbGeAlD
Chlorzoxazone—Urine color abnormal—Capecitabine—prostate cancer	0.00166	0.0215	CcSEcCtD
Chlorzoxazone—Chromaturia—Mitoxantrone—prostate cancer	0.00164	0.0211	CcSEcCtD
Chlorzoxazone—KCNMA1—prostate gland—prostate cancer	0.00164	0.0824	CbGeAlD
Chlorzoxazone—CYP3A4—urine—prostate cancer	0.00145	0.0729	CbGeAlD
Chlorzoxazone—CYP2D6—urine—prostate cancer	0.00143	0.0717	CbGeAlD
Chlorzoxazone—Ecchymosis—Flutamide—prostate cancer	0.00142	0.0183	CcSEcCtD
Chlorzoxazone—CYP2A6—prostate gland—prostate cancer	0.00137	0.0688	CbGeAlD
Chlorzoxazone—Gastrointestinal haemorrhage—Estramustine—prostate cancer	0.00129	0.0167	CcSEcCtD
Chlorzoxazone—KCNMA1—epithelium—prostate cancer	0.0012	0.0605	CbGeAlD
Chlorzoxazone—CYP2A6—seminal vesicle—prostate cancer	0.00116	0.0582	CbGeAlD
Chlorzoxazone—Gastrointestinal haemorrhage—Nilutamide—prostate cancer	0.00114	0.0148	CcSEcCtD
Chlorzoxazone—KCNMA1—renal system—prostate cancer	0.00112	0.0561	CbGeAlD
Chlorzoxazone—Chromaturia—Capecitabine—prostate cancer	0.0011	0.0142	CcSEcCtD
Chlorzoxazone—Ecchymosis—Bicalutamide—prostate cancer	0.00103	0.0133	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Cabazitaxel—prostate cancer	0.000964	0.0124	CcSEcCtD
Chlorzoxazone—Drowsiness—Flutamide—prostate cancer	0.000878	0.0113	CcSEcCtD
Chlorzoxazone—KCNMA1—testis—prostate cancer	0.000722	0.0363	CbGeAlD
Chlorzoxazone—Ecchymosis—Goserelin—prostate cancer	0.000716	0.00924	CcSEcCtD
Chlorzoxazone—Petechiae—Mitoxantrone—prostate cancer	0.000711	0.00918	CcSEcCtD
Chlorzoxazone—Lightheadedness—Conjugated Estrogens—prostate cancer	0.000702	0.00906	CcSEcCtD
Chlorzoxazone—Angioedema—Estrone—prostate cancer	0.000678	0.00876	CcSEcCtD
Chlorzoxazone—CYP2E1—prostate gland—prostate cancer	0.000647	0.0325	CbGeAlD
Chlorzoxazone—Ill-defined disorder—Nilutamide—prostate cancer	0.00064	0.00826	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Flutamide—prostate cancer	0.000637	0.00822	CcSEcCtD
Chlorzoxazone—Discomfort—Abiraterone—prostate cancer	0.000635	0.00819	CcSEcCtD
Chlorzoxazone—Malaise—Nilutamide—prostate cancer	0.000622	0.00803	CcSEcCtD
Chlorzoxazone—Malaise—Flutamide—prostate cancer	0.000619	0.00799	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Estrone—prostate cancer	0.000606	0.00782	CcSEcCtD
Chlorzoxazone—Angioedema—Estradiol valerate/Dienogest—prostate cancer	0.000592	0.00764	CcSEcCtD
Chlorzoxazone—Discomfort—Nilutamide—prostate cancer	0.00058	0.00749	CcSEcCtD
Chlorzoxazone—Discomfort—Flutamide—prostate cancer	0.000577	0.00745	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Degarelix—prostate cancer	0.000572	0.00738	CcSEcCtD
Chlorzoxazone—Malaise—Degarelix—prostate cancer	0.000555	0.00717	CcSEcCtD
Chlorzoxazone—CYP2E1—seminal vesicle—prostate cancer	0.000547	0.0275	CbGeAlD
Chlorzoxazone—Dyspepsia—Abiraterone—prostate cancer	0.000542	0.007	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Cabazitaxel—prostate cancer	0.000538	0.00695	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Abiraterone—prostate cancer	0.000532	0.00686	CcSEcCtD
Chlorzoxazone—Ecchymosis—Mitoxantrone—prostate cancer	0.000529	0.00683	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.000529	0.00683	CcSEcCtD
Chlorzoxazone—Malaise—Cabazitaxel—prostate cancer	0.000523	0.00675	CcSEcCtD
Chlorzoxazone—KCNMA1—lymph node—prostate cancer	0.000523	0.0263	CbGeAlD
Chlorzoxazone—CYP1A1—epithelium—prostate cancer	0.000521	0.0262	CbGeAlD
Chlorzoxazone—Discomfort—Degarelix—prostate cancer	0.000518	0.00669	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Degarelix—prostate cancer	0.000503	0.00649	CcSEcCtD
Chlorzoxazone—Somnolence—Flutamide—prostate cancer	0.000498	0.00643	CcSEcCtD
Chlorzoxazone—Dyspepsia—Nilutamide—prostate cancer	0.000495	0.00639	CcSEcCtD
Chlorzoxazone—CYP1A2—renal system—prostate cancer	0.00049	0.0246	CbGeAlD
Chlorzoxazone—Discomfort—Cabazitaxel—prostate cancer	0.000488	0.0063	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Nilutamide—prostate cancer	0.000486	0.00627	CcSEcCtD
Chlorzoxazone—CYP1A1—renal system—prostate cancer	0.000483	0.0243	CbGeAlD
Chlorzoxazone—Petechiae—Capecitabine—prostate cancer	0.000476	0.00614	CcSEcCtD
Chlorzoxazone—CYP1A1—urethra—prostate cancer	0.000475	0.0239	CbGeAlD
Chlorzoxazone—Dyspepsia—Estradiol valerate/Dienogest—prostate cancer	0.000465	0.00601	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Nilutamide—prostate cancer	0.000464	0.00599	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Flutamide—prostate cancer	0.000462	0.00596	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Estradiol valerate/Dienogest—prostate cancer	0.000456	0.00589	CcSEcCtD
Chlorzoxazone—Angioedema—Bicalutamide—prostate cancer	0.000455	0.00587	CcSEcCtD
Chlorzoxazone—Drowsiness—Goserelin—prostate cancer	0.000443	0.00572	CcSEcCtD
Chlorzoxazone—CYP2E1—renal system—prostate cancer	0.000441	0.0222	CbGeAlD
Chlorzoxazone—Gastrointestinal disorder—Degarelix—prostate cancer	0.000434	0.0056	CcSEcCtD
Chlorzoxazone—CYP2E1—urethra—prostate cancer	0.000433	0.0218	CbGeAlD
Chlorzoxazone—Gastrointestinal haemorrhage—Mitoxantrone—prostate cancer	0.000425	0.00548	CcSEcCtD
Chlorzoxazone—Petechiae—Prednisone—prostate cancer	0.000424	0.00547	CcSEcCtD
Chlorzoxazone—Dyspepsia—Cabazitaxel—prostate cancer	0.000417	0.00538	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Degarelix—prostate cancer	0.000414	0.00535	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Cabazitaxel—prostate cancer	0.000409	0.00528	CcSEcCtD
Chlorzoxazone—Dizziness—Estrone—prostate cancer	0.000401	0.00517	CcSEcCtD
Chlorzoxazone—Rash—Estramustine—prostate cancer	0.0004	0.00516	CcSEcCtD
Chlorzoxazone—Dermatitis—Estramustine—prostate cancer	0.0004	0.00516	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Ethinyl Estradiol—prostate cancer	0.00039	0.00504	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Cabazitaxel—prostate cancer	0.00039	0.00504	CcSEcCtD
Chlorzoxazone—Rash—Abiraterone—prostate cancer	0.000388	0.00501	CcSEcCtD
Chlorzoxazone—Dermatitis—Abiraterone—prostate cancer	0.000388	0.00501	CcSEcCtD
Chlorzoxazone—Angioedema—Ethinyl Estradiol—prostate cancer	0.000384	0.00496	CcSEcCtD
Chlorzoxazone—Rash—Estrone—prostate cancer	0.000382	0.00493	CcSEcCtD
Chlorzoxazone—Dermatitis—Estrone—prostate cancer	0.000382	0.00493	CcSEcCtD
Chlorzoxazone—Malaise—Ethinyl Estradiol—prostate cancer	0.000379	0.0049	CcSEcCtD
Chlorzoxazone—Dizziness—Nilutamide—prostate cancer	0.000372	0.0048	CcSEcCtD
Chlorzoxazone—Dizziness—Flutamide—prostate cancer	0.00037	0.00478	CcSEcCtD
Chlorzoxazone—Lightheadedness—Docetaxel—prostate cancer	0.000362	0.00467	CcSEcCtD
Chlorzoxazone—Somnolence—Bicalutamide—prostate cancer	0.000361	0.00466	CcSEcCtD
Chlorzoxazone—Dyspepsia—Bicalutamide—prostate cancer	0.000358	0.00462	CcSEcCtD
Chlorzoxazone—Rash—Nilutamide—prostate cancer	0.000355	0.00458	CcSEcCtD
Chlorzoxazone—CYP3A4—renal system—prostate cancer	0.000355	0.0178	CbGeAlD
Chlorzoxazone—Dermatitis—Nilutamide—prostate cancer	0.000354	0.00458	CcSEcCtD
Chlorzoxazone—Ecchymosis—Capecitabine—prostate cancer	0.000354	0.00457	CcSEcCtD
Chlorzoxazone—Discomfort—Ethinyl Estradiol—prostate cancer	0.000354	0.00457	CcSEcCtD
Chlorzoxazone—Rash—Flutamide—prostate cancer	0.000353	0.00456	CcSEcCtD
Chlorzoxazone—Dermatitis—Flutamide—prostate cancer	0.000353	0.00456	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.000351	0.00453	CcSEcCtD
Chlorzoxazone—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00035	0.00451	CcSEcCtD
Chlorzoxazone—CYP2D6—renal system—prostate cancer	0.000349	0.0175	CbGeAlD
Chlorzoxazone—Feeling abnormal—Bicalutamide—prostate cancer	0.000335	0.00432	CcSEcCtD
Chlorzoxazone—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000333	0.0043	CcSEcCtD
Chlorzoxazone—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000333	0.0043	CcSEcCtD
Chlorzoxazone—Dizziness—Degarelix—prostate cancer	0.000332	0.00429	CcSEcCtD
Chlorzoxazone—Petechiae—Epirubicin—prostate cancer	0.000332	0.00428	CcSEcCtD
Chlorzoxazone—Drowsiness—Mitoxantrone—prostate cancer	0.000327	0.00422	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Goserelin—prostate cancer	0.000321	0.00415	CcSEcCtD
Chlorzoxazone—Rash—Degarelix—prostate cancer	0.000317	0.00409	CcSEcCtD
Chlorzoxazone—Dermatitis—Degarelix—prostate cancer	0.000317	0.00409	CcSEcCtD
Chlorzoxazone—Ecchymosis—Prednisone—prostate cancer	0.000315	0.00407	CcSEcCtD
Chlorzoxazone—Angioedema—Conjugated Estrogens—prostate cancer	0.000313	0.00405	CcSEcCtD
Chlorzoxazone—Dizziness—Cabazitaxel—prostate cancer	0.000313	0.00404	CcSEcCtD
Chlorzoxazone—Malaise—Goserelin—prostate cancer	0.000312	0.00403	CcSEcCtD
Chlorzoxazone—Petechiae—Doxorubicin—prostate cancer	0.000307	0.00396	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.000296	0.00383	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Docetaxel—prostate cancer	0.000294	0.00379	CcSEcCtD
Chlorzoxazone—Discomfort—Goserelin—prostate cancer	0.000291	0.00376	CcSEcCtD
Chlorzoxazone—CYP2E1—testis—prostate cancer	0.000285	0.0143	CbGeAlD
Chlorzoxazone—Gastrointestinal haemorrhage—Capecitabine—prostate cancer	0.000284	0.00367	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.000283	0.00365	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Goserelin—prostate cancer	0.000283	0.00365	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.00028	0.00361	CcSEcCtD
Chlorzoxazone—Dizziness—Bicalutamide—prostate cancer	0.000269	0.00347	CcSEcCtD
Chlorzoxazone—Rash—Bicalutamide—prostate cancer	0.000256	0.00331	CcSEcCtD
Chlorzoxazone—Dermatitis—Bicalutamide—prostate cancer	0.000256	0.0033	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Estradiol—prostate cancer	0.000255	0.00329	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Prednisone—prostate cancer	0.000253	0.00327	CcSEcCtD
Chlorzoxazone—Somnolence—Goserelin—prostate cancer	0.000251	0.00324	CcSEcCtD
Chlorzoxazone—Angioedema—Estradiol—prostate cancer	0.000251	0.00324	CcSEcCtD
Chlorzoxazone—Somnolence—Conjugated Estrogens—prostate cancer	0.000249	0.00321	CcSEcCtD
Chlorzoxazone—Dyspepsia—Goserelin—prostate cancer	0.000249	0.00321	CcSEcCtD
Chlorzoxazone—Malaise—Estradiol—prostate cancer	0.000248	0.0032	CcSEcCtD
Chlorzoxazone—Ecchymosis—Epirubicin—prostate cancer	0.000247	0.00318	CcSEcCtD
Chlorzoxazone—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000246	0.00318	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000242	0.00312	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Mitoxantrone—prostate cancer	0.000237	0.00306	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Goserelin—prostate cancer	0.000233	0.00301	CcSEcCtD
Chlorzoxazone—Discomfort—Estradiol—prostate cancer	0.000231	0.00298	CcSEcCtD
Chlorzoxazone—Malaise—Mitoxantrone—prostate cancer	0.000231	0.00298	CcSEcCtD
Chlorzoxazone—Ecchymosis—Doxorubicin—prostate cancer	0.000228	0.00295	CcSEcCtD
Chlorzoxazone—Dizziness—Ethinyl Estradiol—prostate cancer	0.000227	0.00293	CcSEcCtD
Chlorzoxazone—CYP1A1—lymph node—prostate cancer	0.000226	0.0114	CbGeAlD
Chlorzoxazone—CYP2D6—testis—prostate cancer	0.000226	0.0113	CbGeAlD
Chlorzoxazone—Anaphylactic shock—Estradiol—prostate cancer	0.000224	0.00289	CcSEcCtD
Chlorzoxazone—Rash—Ethinyl Estradiol—prostate cancer	0.000217	0.00279	CcSEcCtD
Chlorzoxazone—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000216	0.00279	CcSEcCtD
Chlorzoxazone—Discomfort—Mitoxantrone—prostate cancer	0.000215	0.00278	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000209	0.00269	CcSEcCtD
Chlorzoxazone—Somnolence—Estradiol—prostate cancer	0.000199	0.00257	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	0.000198	0.00256	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Etoposide—prostate cancer	0.000197	0.00255	CcSEcCtD
Chlorzoxazone—Dyspepsia—Estradiol—prostate cancer	0.000197	0.00255	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Estradiol—prostate cancer	0.000193	0.0025	CcSEcCtD
Chlorzoxazone—Malaise—Etoposide—prostate cancer	0.000192	0.00248	CcSEcCtD
Chlorzoxazone—Dizziness—Goserelin—prostate cancer	0.000187	0.00241	CcSEcCtD
Chlorzoxazone—Somnolence—Mitoxantrone—prostate cancer	0.000186	0.0024	CcSEcCtD
Chlorzoxazone—Dizziness—Conjugated Estrogens—prostate cancer	0.000185	0.00239	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Estradiol—prostate cancer	0.000185	0.00238	CcSEcCtD
Chlorzoxazone—Dyspepsia—Mitoxantrone—prostate cancer	0.000184	0.00237	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	0.000183	0.00237	CcSEcCtD
Chlorzoxazone—Discomfort—Etoposide—prostate cancer	0.000179	0.00231	CcSEcCtD
Chlorzoxazone—Rash—Goserelin—prostate cancer	0.000178	0.0023	CcSEcCtD
Chlorzoxazone—Dermatitis—Goserelin—prostate cancer	0.000178	0.0023	CcSEcCtD
Chlorzoxazone—Rash—Conjugated Estrogens—prostate cancer	0.000176	0.00228	CcSEcCtD
Chlorzoxazone—Dermatitis—Conjugated Estrogens—prostate cancer	0.000176	0.00228	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Etoposide—prostate cancer	0.000174	0.00224	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Mitoxantrone—prostate cancer	0.000172	0.00222	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Capecitabine—prostate cancer	0.000159	0.00205	CcSEcCtD
Chlorzoxazone—Malaise—Capecitabine—prostate cancer	0.000154	0.00199	CcSEcCtD
Chlorzoxazone—Somnolence—Etoposide—prostate cancer	0.000154	0.00199	CcSEcCtD
Chlorzoxazone—Drowsiness—Epirubicin—prostate cancer	0.000153	0.00197	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Etoposide—prostate cancer	0.00015	0.00193	CcSEcCtD
Chlorzoxazone—Dizziness—Estradiol—prostate cancer	0.000148	0.00191	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Docetaxel—prostate cancer	0.000144	0.00186	CcSEcCtD
Chlorzoxazone—Discomfort—Capecitabine—prostate cancer	0.000144	0.00186	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Etoposide—prostate cancer	0.000143	0.00185	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Prednisone—prostate cancer	0.000141	0.00183	CcSEcCtD
Chlorzoxazone—Rash—Estradiol—prostate cancer	0.000141	0.00182	CcSEcCtD
Chlorzoxazone—Drowsiness—Doxorubicin—prostate cancer	0.000141	0.00182	CcSEcCtD
Chlorzoxazone—Dermatitis—Estradiol—prostate cancer	0.000141	0.00182	CcSEcCtD
Chlorzoxazone—Angioedema—Prednisone—prostate cancer	0.000139	0.0018	CcSEcCtD
Chlorzoxazone—Malaise—Prednisone—prostate cancer	0.000138	0.00177	CcSEcCtD
Chlorzoxazone—Rash—Mitoxantrone—prostate cancer	0.000132	0.0017	CcSEcCtD
Chlorzoxazone—Dermatitis—Mitoxantrone—prostate cancer	0.000131	0.0017	CcSEcCtD
Chlorzoxazone—Somnolence—Docetaxel—prostate cancer	0.000128	0.00166	CcSEcCtD
Chlorzoxazone—Discomfort—Prednisone—prostate cancer	0.000128	0.00166	CcSEcCtD
Chlorzoxazone—Dyspepsia—Docetaxel—prostate cancer	0.000127	0.00164	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000125	0.00161	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Prednisone—prostate cancer	0.000124	0.00161	CcSEcCtD
Chlorzoxazone—Dyspepsia—Capecitabine—prostate cancer	0.000123	0.00159	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000121	0.00156	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Docetaxel—prostate cancer	0.000119	0.00153	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Capecitabine—prostate cancer	0.000115	0.00149	CcSEcCtD
Chlorzoxazone—Dizziness—Etoposide—prostate cancer	0.000115	0.00148	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Epirubicin—prostate cancer	0.000111	0.00143	CcSEcCtD
Chlorzoxazone—Dyspepsia—Prednisone—prostate cancer	0.00011	0.00141	CcSEcCtD
Chlorzoxazone—Rash—Etoposide—prostate cancer	0.000109	0.00141	CcSEcCtD
Chlorzoxazone—Dermatitis—Etoposide—prostate cancer	0.000109	0.00141	CcSEcCtD
Chlorzoxazone—Malaise—Epirubicin—prostate cancer	0.000108	0.00139	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Prednisone—prostate cancer	0.000103	0.00132	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Doxorubicin—prostate cancer	0.000102	0.00132	CcSEcCtD
Chlorzoxazone—Discomfort—Epirubicin—prostate cancer	0.0001	0.00129	CcSEcCtD
Chlorzoxazone—Malaise—Doxorubicin—prostate cancer	9.95e-05	0.00128	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Epirubicin—prostate cancer	9.73e-05	0.00126	CcSEcCtD
Chlorzoxazone—Dizziness—Docetaxel—prostate cancer	9.54e-05	0.00123	CcSEcCtD
Chlorzoxazone—Discomfort—Doxorubicin—prostate cancer	9.28e-05	0.0012	CcSEcCtD
Chlorzoxazone—Dizziness—Capecitabine—prostate cancer	9.24e-05	0.00119	CcSEcCtD
Chlorzoxazone—Rash—Docetaxel—prostate cancer	9.1e-05	0.00117	CcSEcCtD
Chlorzoxazone—Dermatitis—Docetaxel—prostate cancer	9.09e-05	0.00117	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Doxorubicin—prostate cancer	9.01e-05	0.00116	CcSEcCtD
Chlorzoxazone—Rash—Capecitabine—prostate cancer	8.81e-05	0.00114	CcSEcCtD
Chlorzoxazone—Dermatitis—Capecitabine—prostate cancer	8.8e-05	0.00114	CcSEcCtD
Chlorzoxazone—Somnolence—Epirubicin—prostate cancer	8.65e-05	0.00112	CcSEcCtD
Chlorzoxazone—Dyspepsia—Epirubicin—prostate cancer	8.57e-05	0.00111	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Epirubicin—prostate cancer	8.4e-05	0.00108	CcSEcCtD
Chlorzoxazone—Dizziness—Prednisone—prostate cancer	8.23e-05	0.00106	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Epirubicin—prostate cancer	8.02e-05	0.00104	CcSEcCtD
Chlorzoxazone—Somnolence—Doxorubicin—prostate cancer	8.01e-05	0.00103	CcSEcCtD
Chlorzoxazone—Dyspepsia—Doxorubicin—prostate cancer	7.93e-05	0.00102	CcSEcCtD
Chlorzoxazone—Rash—Prednisone—prostate cancer	7.85e-05	0.00101	CcSEcCtD
Chlorzoxazone—Dermatitis—Prednisone—prostate cancer	7.84e-05	0.00101	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Doxorubicin—prostate cancer	7.77e-05	0.001	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Doxorubicin—prostate cancer	7.42e-05	0.000958	CcSEcCtD
Chlorzoxazone—Dizziness—Epirubicin—prostate cancer	6.44e-05	0.000831	CcSEcCtD
Chlorzoxazone—Rash—Epirubicin—prostate cancer	6.14e-05	0.000792	CcSEcCtD
Chlorzoxazone—Dermatitis—Epirubicin—prostate cancer	6.13e-05	0.000791	CcSEcCtD
Chlorzoxazone—Dizziness—Doxorubicin—prostate cancer	5.96e-05	0.000769	CcSEcCtD
Chlorzoxazone—Rash—Doxorubicin—prostate cancer	5.68e-05	0.000733	CcSEcCtD
Chlorzoxazone—Dermatitis—Doxorubicin—prostate cancer	5.67e-05	0.000732	CcSEcCtD
Chlorzoxazone—CYP1A1—Metabolism—NQO1—prostate cancer	4.12e-06	4.15e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HSD3B2—prostate cancer	4.08e-06	4.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTO1—prostate cancer	4.08e-06	4.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NAT2—prostate cancer	4.08e-06	4.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—TH—prostate cancer	4.06e-06	4.09e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GGT1—prostate cancer	4.06e-06	4.09e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.04e-06	4.07e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NCOA3—prostate cancer	4.04e-06	4.06e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CYP1A1—prostate cancer	4.02e-06	4.05e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP3A4—prostate cancer	4.02e-06	4.05e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4e-06	4.03e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NCOA1—prostate cancer	4e-06	4.03e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—ERCC2—prostate cancer	3.99e-06	4.02e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ARG2—prostate cancer	3.98e-06	4.01e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PHGDH—prostate cancer	3.98e-06	4.01e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—UMPS—prostate cancer	3.98e-06	4.01e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP1B1—prostate cancer	3.95e-06	3.98e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYP19A1—prostate cancer	3.94e-06	3.97e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	3.92e-06	3.95e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PLCB2—prostate cancer	3.91e-06	3.94e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—LRP2—prostate cancer	3.91e-06	3.94e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP2C18—prostate cancer	3.91e-06	3.94e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—LDHB—prostate cancer	3.91e-06	3.93e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—HPGDS—prostate cancer	3.85e-06	3.88e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—P4HB—prostate cancer	3.84e-06	3.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.83e-06	3.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GGT1—prostate cancer	3.83e-06	3.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP2C19—prostate cancer	3.83e-06	3.85e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—RXRA—prostate cancer	3.8e-06	3.83e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NCOA1—prostate cancer	3.77e-06	3.8e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—MTHFR—prostate cancer	3.75e-06	3.78e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTT1—prostate cancer	3.73e-06	3.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ACHE—prostate cancer	3.73e-06	3.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SLC22A1—prostate cancer	3.73e-06	3.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP19A1—prostate cancer	3.72e-06	3.74e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—UCP3—prostate cancer	3.7e-06	3.73e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTA3—prostate cancer	3.7e-06	3.73e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PDHA1—prostate cancer	3.7e-06	3.73e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—TCN2—prostate cancer	3.7e-06	3.73e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP2A6—prostate cancer	3.69e-06	3.72e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.69e-06	3.71e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PPARA—prostate cancer	3.68e-06	3.7e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—COMT—prostate cancer	3.66e-06	3.69e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTP1—prostate cancer	3.65e-06	3.67e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SULT2A1—prostate cancer	3.64e-06	3.66e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—AKR1C3—prostate cancer	3.59e-06	3.62e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ITPR1—prostate cancer	3.59e-06	3.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—RXRA—prostate cancer	3.59e-06	3.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—MED12—prostate cancer	3.58e-06	3.6e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PRKACB—prostate cancer	3.57e-06	3.6e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GNG5—prostate cancer	3.55e-06	3.57e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP17A1—prostate cancer	3.53e-06	3.56e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.53e-06	3.56e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.53e-06	3.56e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.49e-06	3.51e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CAV1—prostate cancer	3.46e-06	3.48e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—COMT—prostate cancer	3.46e-06	3.48e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTP1—prostate cancer	3.44e-06	3.46e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NCOA3—prostate cancer	3.42e-06	3.44e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—TYMS—prostate cancer	3.39e-06	3.42e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTA4—prostate cancer	3.39e-06	3.41e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.39e-06	3.41e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ITPR1—prostate cancer	3.38e-06	3.41e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NCOA2—prostate cancer	3.37e-06	3.39e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.36e-06	3.38e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTM1—prostate cancer	3.35e-06	3.38e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.33e-06	3.35e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTA2—prostate cancer	3.3e-06	3.32e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—LPL—prostate cancer	3.29e-06	3.31e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HPGDS—prostate cancer	3.26e-06	3.28e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ABCG5—prostate cancer	3.26e-06	3.28e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.26e-06	3.28e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP2C19—prostate cancer	3.24e-06	3.26e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SLC5A5—prostate cancer	3.21e-06	3.24e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—TYMS—prostate cancer	3.2e-06	3.22e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTA1—prostate cancer	3.18e-06	3.21e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYP1A1—prostate cancer	3.18e-06	3.2e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTT1—prostate cancer	3.16e-06	3.19e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ACHE—prostate cancer	3.16e-06	3.19e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTM1—prostate cancer	3.16e-06	3.18e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ERCC2—prostate cancer	3.15e-06	3.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PIK3CG—prostate cancer	3.15e-06	3.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTO1—prostate cancer	3.15e-06	3.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.15e-06	3.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NAT2—prostate cancer	3.15e-06	3.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP2E1—prostate cancer	3.14e-06	3.16e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP2A6—prostate cancer	3.13e-06	3.15e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.11e-06	3.14e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NQO1—prostate cancer	3.1e-06	3.13e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—LPL—prostate cancer	3.1e-06	3.12e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—TH—prostate cancer	3.06e-06	3.08e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—AKR1C3—prostate cancer	3.04e-06	3.06e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP3A4—prostate cancer	3.03e-06	3.05e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PRKACB—prostate cancer	3.03e-06	3.05e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PLCB2—prostate cancer	3.02e-06	3.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.02e-06	3.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—LRP2—prostate cancer	3.02e-06	3.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP17A1—prostate cancer	2.99e-06	3.02e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—INS—prostate cancer	2.98e-06	3e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.98e-06	3e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ERCC2—prostate cancer	2.97e-06	2.99e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—MTHFR—prostate cancer	2.96e-06	2.98e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—P4HB—prostate cancer	2.96e-06	2.98e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.95e-06	2.97e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CREBBP—prostate cancer	2.92e-06	2.94e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PPARA—prostate cancer	2.91e-06	2.93e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GGT1—prostate cancer	2.88e-06	2.9e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.88e-06	2.9e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NCOA2—prostate cancer	2.85e-06	2.87e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NCOA1—prostate cancer	2.84e-06	2.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.81e-06	2.83e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.8e-06	2.82e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—MTHFR—prostate cancer	2.79e-06	2.81e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PIK3CD—prostate cancer	2.77e-06	2.79e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—MED12—prostate cancer	2.76e-06	2.78e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PPARA—prostate cancer	2.74e-06	2.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GNG5—prostate cancer	2.74e-06	2.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CAV1—prostate cancer	2.73e-06	2.75e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.72e-06	2.74e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—RXRA—prostate cancer	2.7e-06	2.72e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.66e-06	2.68e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NCOA3—prostate cancer	2.64e-06	2.66e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NQO1—prostate cancer	2.63e-06	2.65e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—NOS3—prostate cancer	2.61e-06	2.63e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—COMT—prostate cancer	2.6e-06	2.62e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—TH—prostate cancer	2.59e-06	2.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTP1—prostate cancer	2.59e-06	2.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CAV1—prostate cancer	2.58e-06	2.59e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.57e-06	2.59e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.56e-06	2.58e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.55e-06	2.57e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ITPR1—prostate cancer	2.55e-06	2.57e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.52e-06	2.54e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HPGDS—prostate cancer	2.52e-06	2.54e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.5e-06	2.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PIK3CG—prostate cancer	2.49e-06	2.51e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.46e-06	2.48e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ACHE—prostate cancer	2.44e-06	2.46e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTT1—prostate cancer	2.44e-06	2.46e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GGT1—prostate cancer	2.44e-06	2.46e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.41e-06	2.43e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PIK3CB—prostate cancer	2.41e-06	2.43e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—TYMS—prostate cancer	2.41e-06	2.42e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NCOA1—prostate cancer	2.4e-06	2.42e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PTGS2—prostate cancer	2.39e-06	2.41e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTM1—prostate cancer	2.38e-06	2.4e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.37e-06	2.39e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—INS—prostate cancer	2.36e-06	2.37e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.35e-06	2.36e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PIK3CG—prostate cancer	2.35e-06	2.36e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PRKACB—prostate cancer	2.34e-06	2.35e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—LPL—prostate cancer	2.33e-06	2.35e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.31e-06	2.33e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CREBBP—prostate cancer	2.31e-06	2.32e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—RXRA—prostate cancer	2.29e-06	2.3e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP1A1—prostate cancer	2.25e-06	2.27e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ERCC2—prostate cancer	2.24e-06	2.25e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.22e-06	2.24e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—INS—prostate cancer	2.22e-06	2.24e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—COMT—prostate cancer	2.2e-06	2.22e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NCOA2—prostate cancer	2.2e-06	2.22e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTP1—prostate cancer	2.19e-06	2.21e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PIK3CD—prostate cancer	2.19e-06	2.2e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CREBBP—prostate cancer	2.18e-06	2.19e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ITPR1—prostate cancer	2.16e-06	2.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.12e-06	2.14e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—MTHFR—prostate cancer	2.1e-06	2.12e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.1e-06	2.12e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PTEN—prostate cancer	2.09e-06	2.1e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NOS3—prostate cancer	2.07e-06	2.08e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PIK3CD—prostate cancer	2.06e-06	2.08e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PPARA—prostate cancer	2.06e-06	2.08e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.05e-06	2.07e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—TYMS—prostate cancer	2.04e-06	2.05e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NQO1—prostate cancer	2.03e-06	2.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTM1—prostate cancer	2.01e-06	2.03e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—TH—prostate cancer	2e-06	2.01e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—EP300—prostate cancer	1.99e-06	2e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—LPL—prostate cancer	1.98e-06	1.99e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NOS3—prostate cancer	1.95e-06	1.96e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.95e-06	1.96e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CAV1—prostate cancer	1.94e-06	1.95e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.91e-06	1.92e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.91e-06	1.92e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ERCC2—prostate cancer	1.89e-06	1.91e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PTGS2—prostate cancer	1.89e-06	1.9e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GGT1—prostate cancer	1.88e-06	1.9e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NCOA1—prostate cancer	1.86e-06	1.87e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.83e-06	1.84e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PIK3CB—prostate cancer	1.8e-06	1.81e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PTGS2—prostate cancer	1.78e-06	1.79e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—MTHFR—prostate cancer	1.78e-06	1.79e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.77e-06	1.78e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—RXRA—prostate cancer	1.77e-06	1.78e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PPARA—prostate cancer	1.75e-06	1.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—COMT—prostate cancer	1.7e-06	1.71e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTP1—prostate cancer	1.69e-06	1.7e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—INS—prostate cancer	1.67e-06	1.68e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ITPR1—prostate cancer	1.67e-06	1.68e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PTEN—prostate cancer	1.65e-06	1.66e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CAV1—prostate cancer	1.64e-06	1.65e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CREBBP—prostate cancer	1.64e-06	1.65e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—TYMS—prostate cancer	1.57e-06	1.58e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—EP300—prostate cancer	1.57e-06	1.58e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.57e-06	1.58e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTM1—prostate cancer	1.56e-06	1.57e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PTEN—prostate cancer	1.55e-06	1.56e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.55e-06	1.56e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—LPL—prostate cancer	1.53e-06	1.54e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.5e-06	1.51e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—EP300—prostate cancer	1.48e-06	1.49e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PIK3CA—prostate cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NOS3—prostate cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ERCC2—prostate cancer	1.46e-06	1.47e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—INS—prostate cancer	1.42e-06	1.43e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CREBBP—prostate cancer	1.39e-06	1.4e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—MTHFR—prostate cancer	1.37e-06	1.38e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.35e-06	1.36e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PPARA—prostate cancer	1.35e-06	1.36e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PTGS2—prostate cancer	1.34e-06	1.35e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.32e-06	1.32e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CAV1—prostate cancer	1.27e-06	1.28e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NOS3—prostate cancer	1.24e-06	1.25e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—AKT1—prostate cancer	1.2e-06	1.21e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PTEN—prostate cancer	1.17e-06	1.18e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PIK3CA—prostate cancer	1.16e-06	1.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.15e-06	1.16e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.15e-06	1.15e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PTGS2—prostate cancer	1.14e-06	1.14e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—EP300—prostate cancer	1.12e-06	1.12e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PIK3CA—prostate cancer	1.1e-06	1.1e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—INS—prostate cancer	1.09e-06	1.1e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CREBBP—prostate cancer	1.07e-06	1.08e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.02e-06	1.02e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PTEN—prostate cancer	9.91e-07	9.98e-06	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NOS3—prostate cancer	9.59e-07	9.65e-06	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—AKT1—prostate cancer	9.5e-07	9.57e-06	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—EP300—prostate cancer	9.45e-07	9.52e-06	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—AKT1—prostate cancer	8.95e-07	9.02e-06	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PIK3CB—prostate cancer	8.85e-07	8.91e-06	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PTGS2—prostate cancer	8.77e-07	8.83e-06	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PIK3CA—prostate cancer	8.25e-07	8.31e-06	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PTEN—prostate cancer	7.65e-07	7.7e-06	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—EP300—prostate cancer	7.29e-07	7.34e-06	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PIK3CA—prostate cancer	6.99e-07	7.04e-06	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—AKT1—prostate cancer	6.74e-07	6.79e-06	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—AKT1—prostate cancer	5.71e-07	5.75e-06	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.39e-07	5.43e-06	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—AKT1—prostate cancer	4.41e-07	4.44e-06	CbGpPWpGaD
